Gorlin Syndrome patient and Trustee of the Gorlin Syndrome Group Sally Webster in the news.

Trustee of the Gorlin Syndrome Group Sally Webster was interviewed by the Manchester Evening News last week in relation to new developments in the treatment of Basal Cell Carcinomas.

Researchers have developed a new medication, a once-a-day pill called Vismodegib, which can shrink tumours and scientists have published the findings of clinical trials in the USA.

Our thanks go to Sally for agreeing to be interviewed and for raising the awareness of Gorlin Syndrome.

Further details of the article can be accessed on the Gorlin Syndrome website.

[Hidden]

Following last weeks article in the Manchester Evening News Sally has again been contacted by the media, this time BBC Radio Manchester and she is due to be interviewed today Monday, 11th June 2012 at 11.30 am.

Mr. John Lear, Consultant Dermatologist at Manchester Royal Infirmary will also participate in the interview.

Tune in to listen to to here what Sally and John have to say.